Page last updated: 2024-11-02

pimobendan and Airflow Obstruction, Chronic

pimobendan has been researched along with Airflow Obstruction, Chronic in 1 studies

pimobendan: produces arterial & venous dilatation in dogs; structure given in first source

Research Excerpts

ExcerptRelevanceReference
"Pimobendan is an inotropic and vasodilating drug with phosphodiesterase (PDE) III-inhibiting and calcium-sensitizing effects."1.31Beta-blocker therapy combined with low-dose pimobendan in patients with idiopathic dilated cardiomyopathy and chronic obstructive pulmonary disease: report on two cases. ( Kajimoto, K; Kasanuki, H; Kawana, M; Matsuda, N; Shiga, T; Wakaumi, M; Yajima, T, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shiga, T1
Wakaumi, M1
Yajima, T1
Kajimoto, K1
Matsuda, N1
Kawana, M1
Kasanuki, H1

Other Studies

1 other study available for pimobendan and Airflow Obstruction, Chronic

ArticleYear
Beta-blocker therapy combined with low-dose pimobendan in patients with idiopathic dilated cardiomyopathy and chronic obstructive pulmonary disease: report on two cases.
    Cardiovascular drugs and therapy, 2002, Volume: 16, Issue:3

    Topics: Adrenergic beta-Antagonists; Cardiomyopathy, Dilated; Drug Therapy, Combination; Humans; Male; Middl

2002